Richard is the founder and leader of PolyPhotonix and is a pioneer in printed electronics material science and its applications. He is credited for many world first applications using inorganic and organic light emitting materials. Richard and PolyPhotonix have won many international and national awards for innovation, research and business.

As the CEO of PolyPhotonix, Richard is spearheading the development of groundbreaking light-based therapies that address major global health challenges like diabetic retinopathy.

Richard’s career reflects a deep commitment to pushing the boundaries of what’s possible; from pioneering printed electronic solutions at Elumin8, to managing global campaigns with Bogle Bartle Hegarty. He has built a reputation for transforming visionary ideas into real-world impact by blending science and creative thinking with robust technical and commercial leadership.

Under Richard’s leadership, PolyPhotonix’s flagship product, the Noctura 400 sleep mask, offers a non-invasive, patient-friendly treatment for diabetic retinopathy, a condition affecting millions worldwide. Richard’s work continues to focus on scaling this life-changing technology, driving strategic partnerships, and shaping the future of non-invasive therapies.